SREBF2 and neoplasm: This leads to activation of SREBF2 and its downstream cholesterol biosynthesis–related genes, promoting enhanced cholesterol biosynthesis in tumor cells, which in turn supports processes such as membrane synthesis, signal transduction, and cell proliferation and survival, ultimately driving tumor progression.